Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions of individuals worldwide, and a major risk factor for disabling cerebral embolic stroke. Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant inherited disorder, characterized by vascular abnormalities with high-bleeding tendency and therefore intolerance for oral anticoagulation. We report a case of percutaneous closure of the left atrial appendage, which might be a good alternative strategy instead of chronic oral anticoagulation to protect patients with high-risk AF and HHT from cerebral embolic strokes.
CITATION STYLE
Velthuis, S., Swaans, M. J., Mager, J. J., Rensing, B. J. W. M., Boersma, L. V. A., & Post, M. C. (2012). Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia. Case Reports in Cardiology, 2012, 1–3. https://doi.org/10.1155/2012/646505
Mendeley helps you to discover research relevant for your work.